The oncology pharmacy in cancer care delivery in a resource-constrained setting in western Kenya

Abstract

The movement to deliver cancer care in resource-limited settings is gaining momentum, with particular emphasis on the creation of cost-effective, rational algorithms utilizing affordable chemotherapeutics to treat curable disease. The delivery of cancer care in resource-replete settings is a concerted effort by a team of multidisciplinary care providers. The oncology pharmacy, which is now considered integral to cancer care in resourced medical practice, developed over the last several decades in an effort to limit healthcare provider exposure to workplace hazards and to limit risk to patients. In developing cancer care services in resource-constrained settings, creation of oncology pharmacies can help to both mitigate the risks to practitioners and patients, and also limit the costs of cancer care and the environmental impact of chemotherapeutics. This article describes the experience and lessons learned in establishing a chemotherapy pharmacy in western Kenya.

Training Global Oncologists: Addressing the Global Cancer Control Problem

“…A few residency programs have incorporated international outreach into their curriculum. Through the Botswana-UPenn Partnership ( 24 ), residents at the University of Pennsylvania and elsewhere can provide clinical care in a LMIC. Similarly, the University of Chicago and the University of California-San Diego allocate time and financial resources for their senior residents to pursue rotations abroad.…”

Locally Advanced Breast Cancer – Strategies for Developing Nations

“…The Academic Model Providing Access to Healthcare (AMPATH) is a successful model of chemotherapy delivery in Kenya, a low-income nation ( 27 ). AMPATH is a collaboration between Moi University School of Medicine in Kenya and North American academic medical centers.…”

Essential medicines for pediatric oncology in developing countries

“…With appropriate adjustment for local realities in LMICs [5], it is possible to deliver chemotherapy safely and effectively to children with cancer in these settings. A central role for pharmacy in such achievements is well described in a report from western Kenya [6]. As previously expressed ''Failure to treat life-threatening diseases such as cancer represents a violation of the fundamental rights of children and of the professional duties of the wider health care community'' [7].…”